--- case_id: "3006" title: "Tasigna (Nilotinib) Products Liability Litigation" research_checked: "2026-10-28" research_level: "documents" screening_approved: false settlement_availability: "not verified" care_availability: "not confirmed" --- # Tasigna (Nilotinib) Products Liability MDL 3006 ## What this matter is about The federal directory identifies Tasigna (Nilotinib) Products Liability as a federal multidistrict-litigation matter. The case title identifies its subject; the index alone does not establish centralization status, detailed allegations, a medical connection, current rulings or settlement terms. Use the linked court documents to review those questions. ## Verified index information - **Full title:** Tasigna (Nilotinib) Products Liability Litigation - **District:** FLM - **Master docket:** 6:21-md-3006 - **Judge:** Dalton, Roy B. - **Index report date:** 2026-10-01 - **Report relationship:** Listed in this report - [JPML report](https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_MDL_Type-October-1-2026.pdf#page=5) ## Preparation roadmap This is a preparation path, not a court schedule or a promise of a payout. 1. **Understand the matter.** Read the case overview and inspect its official sources. Keep allegations separate from findings. 2. **Explore your connection.** Use optional preparation questions. Interest in a matter is not proof of a claim. 3. **Build your record trail.** Product, medicine or device identity, if known. Add only what you already know or can verify. 4. **Make room for care.** Discuss health concerns independently of any legal claim. Clinical decisions belong with your care team. 5. **Choose professional review.** Start with your existing lawyer if represented. A lawyer reviews deadlines, jurisdiction and any filing or settlement options. ## Existing records that may help - Product, medicine or device identity, if known - An approximate timeline and existing receipts or records - Existing clinical reports and treating-team information ## Care information — separate from legal eligibility ### A conversation with your care team If you have a health concern, your existing clinician can review your history and decide whether specialist input is appropriate. Provider access, cost and clinical need depend on your situation. - Which existing records would help explain my concern? - Who should coordinate any follow-up I need? General information: [HRSA: finding affordable health care](https://www.hrsa.gov/get-health-care/affordable). This does not establish product-specific causation or an available appointment. Care may be accessed independently of a lawsuit. Provider fit, licensure, location, insurance, price and appointment availability have not been confirmed. Settlefy does not prescribe treatment, order tests, promise a cure or recommend stopping medication. Optional OPHealth: user-selected signed reports and measurements can be copied for private review. This is not a booked appointment, provider referral or ongoing medical monitoring. No record is sent to a lawyer through that connection. ## Research material and provenance ### Tasigna (Nilotinib) Products Liability Litigation, MDL No. 3006 | Middle District of Florida | United States District Court - [Original source](https://www.flmd.uscourts.gov/cases-of-interest/tasigna-nilotinib-products-liability-litigation-mdl-no-3006) - Access: Retrieved and text-extracted; current legal interpretation still needs professional review - Retrieved: 2026-10-28T23:20:19.878Z - SHA-256: 54c3f9df716d82882c2d2641b83a34422e2d98349447892372a3fd671d63828b ### 11-15-22 TASIGNA STATUS.ecl - [Original source](https://www.flmd.uscourts.gov/sites/flmd/files/documents/transcripts/flmd-transcript-of-november-15-2022-status-conference-6-21-md-3006-rbd-dab_0.pdf) - Access: Retrieved and text-extracted; current legal interpretation still needs professional review - Retrieved: 2026-10-28T23:20:20.153Z - SHA-256: 9035070b61a398311f00fafeb3b1591f407aa8bfaece0105556bb1ca25afd2f4 - Text inspection: first 8 PDF pages; attachments or later pages may not be covered. ### UNITED STATES DISTRICT COURT - [Original source](https://ecf.flmd.uscourts.gov/cgi-bin/show_public_doc?2021-01327-96-6-cv=) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### 047124640490 (1).pdf - [Original source](https://ecf.flmd.uscourts.gov/cgi-bin/show_public_doc?2022-01453-3-6-cv=) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### Case MDL No. 3006 Document 31 Filed 08/10/21 Page 1 of 5 - [Original source](https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3006-Transfer%20Order-07-21.pdf) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ## Research gaps and professional review - Verify the operative complaint, later amendments and current court orders. - Verify any settlement notice, administrator, release, deadline and currently open intake. - Obtain current counsel-approved screening criteria; no eligibility rules are approved here. - Have qualified clinicians review any clinical mapping; general care sources are not case criteria. ## Updates [Live case page and source-update coverage](https://settlefy.com/litigation/3006#case-updates). Source checks run every six hours; most matters have directory-only monitoring. This file is a dated research brief, not an automatically updated court docket. ## Your next step [Explore the preparation questions](https://settlefy.com/my-settlefy?case=3006). Nothing is filed or sent to a firm automatically.